Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MustangSalleyon Apr 01, 2022 1:46pm
204 Views
Post# 34567970

RE:2022 AGM

RE:2022 AGM
donkeyfeathers wrote:

Back at the start of December of last year I posted what I thought was (is) the timeline for what would be considered a DEAL cash infusion worthy of a 6X increase in share value.  The basis for this prediction rests on all the evidence of a lack of real business acumen in this organization.  And, the fact that the retail investors who try and stay somewhat connected on the various and sundry social platforms, seem to have an exceptionally well developed dystopian, or panacea, world view.  This schism is not lost on the manipulators (Can-o-worms, LJ) who actually now call the shots.

Whether you are a passenger on the road to new riches, or feel that the Ray Mathews’ jalopy is racing towards a cliff, putting those two extremes together tells you something about the risk still involved with this play.  That risk is multiplied by the philosophy of those we’ve put in charge of the game plan.  Once again we’re going to hear that we retail investors really don’t appreciate how complex this endeavour is, and that we should feel grateful for everything accomplished so far.  That Jwall’s “Something” or Luke trader’s “timeline to the top,” although attractive, are just ways of keeping the great unwashed preoccupied.  Then there’s the folk who’ve actually seen up close the types of amateur hour moves made by Phillip and the board, and are doing everything they can to undermine confidences (cough cough…reveal the weak decision-making capacities).

This team (the $30 million investor/owners and the executives in charge) have their agenda (including shorting the stock when ever convenient).  If nothing else, Phillip and Frank have become expert at deflecting and foot dragging and coming up with ways to enrich themselves off Dr. White’s idea.  As for the rest of us, well, we’ll get ours too if we stay out of the way and let the science play out.  Quite honestly, that’s the bargain you’ve made if you’re still around after more than a decade of support.  If you’re still happy with that, you’ll avoid conflict at the AGM.  If like me you know that there will not be a fundamental change course unless Phillip and Frank are forced to get some competency in as business lead, you vote against the “let’s insulate ourselves” strategy, that’s been going on now for 4+ years.  And no, the answer isn’t sell and move on if you don’t like it.  The answer is, make sure that you don’t have a deadline when you need to see this thing to blow up (either enriching or go splat).  Have your finger on the trade button at all times, and only have money here that you can afford to lose…cuz once again the gang at SVA are giving themselves free ones, and appear to want to continue on that path, till the rest of us stand up to the reality and do something to change it.
DF



Last year I strongly suggested that shareholders send a message to the board and vote against the compensation package of Dsu's . Dsu's were for to hire more staff the novice shareholders were told . Where did the dsu's go ? David Swetlow ( Ray Matthews Buddy and glorified bookeeper got 5 million , Toleikis took another 6 to 7 million and the guy who orchestrated Dsu at the last minute , Frank ( how do you like my moustache now) Holler got tons . Risk free ride at $1.30 for management . If management delivered and created value for shareholders perhaps they deserve them. On top of that  a pharma deal was promised last year to garner votes for the AGM. Another year passes by, no deal, more expenses and pay raises, Dsu's, no noticeably movement on the scientific front .  

The reason why AGM is now is because under venture management does not have to disclose the votes. Under Tsx, votes have to be disclosed.  

Remember if you don't vote for management , you won't see the deal ...... why make promises and give deadlines to shareholders in the first place ? No credibility . Wait I bet they have hired another or firm .  Company will have to raise lots of money for a clinical trial for stem cells and immunotherapy which is many years away.  Big pharma can wait until there is more progress on the clinical side for stem cells and immunotherapy ... they is no rush to buy the company ...hence no likelihood increase in share price.

It was last year to vote them out or vote against Dsu, the AGM will be rigged like last year .  Expect phone calls to investors to shore up votes in the coming weeks.  Seems like some things never change at Sva over the past ten years .

As Sonny would say " Not my monkey , not my Zoo!" 


My guess there will be no news before AGM and afterwards . Perhaps before end of the year they LL update 7 patient.  Nothing on hemo, thyroid , no business plan and Nasdaq before the end of the year !!  Lol good one ...maybe get the Tsx uplift first .

MS
 

<< Previous
Bullboard Posts
Next >>